Differential oestrogen receptor binding is associated with clinical outcome in breast cancer
2012 · Nature · 2,322 citations
https://doi.org/10.1038/nature10730
M
Mark Dunning
Insigneo(GB)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
105
Papers
19.1K
Citations
35
h-index
47
i10-index
Mark Dunning is an academic researcher from Insigneo. The author has contributed to research in topics: Gene expression and cancer classification & Cancer Genomics and Diagnostics & Prostate Cancer Treatment and Research. The author has an h-index of 35, co-authored 90 publications.
ORCID: 0000-0002-8853-9435Papers by this author
worksQuantitative Image Analysis of Cellular Heterogeneity in Breast Tumors Complements Genomic Profiling
2012 · Science Translational Medicine · 426 citations
https://doi.org/10.1126/scitranslmed.3004330
Neuroendocrine differentiation of prostate cancer leads to PSMA suppression
2018 · Endocrine Related Cancer · 174 citations
https://doi.org/10.1530/erc-18-0226
The pitfalls of platform comparison: DNA copy number array technologies assessed
2009 · BMC Genomics · 97 citations
https://doi.org/10.1186/1471-2164-10-588
5-hydroxymethylcytosine marks promoters in colon that resist DNA hypermethylation in cancer
2015 · Genome Biology · 80 citations
https://doi.org/10.1186/s13059-015-0605-5
Mining Human Prostate Cancer Datasets: The “camcAPP” Shiny App
2017 · EBioMedicine · 36 citations
https://doi.org/10.1016/j.ebiom.2017.02.022
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat